You are using an outdated browser. For a faster, safer browsing experience, upgrade for free today.

Medical Care

Intravenous Ibuprofen Market Status and Trend Analysis 2017-2026 (COVID-19 Version)

Summary

Further key aspects of the report indicate that:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary.

The global Intravenous Ibuprofen market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for @@@@@ are the significant development of demand and improvement of COVID-19 and geo-economics.

Based on the type of product, the global Intravenous Ibuprofen market segmented into
Pain
Inflammatory
Fever

Based on the end-use, the global Intravenous Ibuprofen market classified into
Pediatrics
Adults
Other

Based on geography, the global Intravenous Ibuprofen market segmented into
North America [U.S., Canada, Mexico]
Europe [Germany, UK, France, Italy, Rest of Europe]
Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
South America [Brazil, Argentina, Rest of Latin America]
Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]

And the major players included in the report are
Cumberland Pharmaceuticals Inc
Alveda Pharmaceuticals
Teligent
CSL Limited
Sandor Medicaids
Soho Industri Pharmasi
Germin MED
Grifols
Harbin Gloria Pharmaceuticals
Al Nabeel International Ltd
Laboratorios Valmorca
Table of Contents
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL INTRAVENOUS IBUPROFEN INDUSTRY
2.1 Summary about Intravenous Ibuprofen Industry
2.2 Intravenous Ibuprofen Market Trends
2.2.1 Intravenous Ibuprofen Production & Consumption Trends
2.2.2 Intravenous Ibuprofen Demand Structure Trends
2.3 Intravenous Ibuprofen Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Pain
4.2.2 Inflammatory
4.2.3 Fever
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Pediatrics
4.3.2 Adults
4.3.3 Other
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Pain
5.2.2 Inflammatory
5.2.3 Fever
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Pediatrics
5.3.2 Adults
5.3.3 Other
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Pain
6.2.2 Inflammatory
6.2.3 Fever
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Pediatrics
6.3.2 Adults
6.3.3 Other
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Pain
7.2.2 Inflammatory
7.2.3 Fever
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Pediatrics
7.3.2 Adults
7.3.3 Other
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Pain
8.2.2 Inflammatory
8.2.3 Fever
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Pediatrics
8.3.2 Adults
8.3.3 Other
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Pain
9.2.2 Inflammatory
9.2.3 Fever
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Pediatrics
9.3.2 Adults
9.3.3 Other
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Cumberland Pharmaceuticals Inc
10.1.2 Alveda Pharmaceuticals
10.1.3 Teligent
10.1.4 CSL Limited
10.1.5 Sandor Medicaids
10.1.6 Soho Industri Pharmasi
10.1.7 Germin MED
10.1.8 Grifols
10.1.9 Harbin Gloria Pharmaceuticals
10.1.10 Al Nabeel International Ltd
10.1.11 Laboratorios Valmorca
10.2 Intravenous Ibuprofen Sales Date of Major Players (2017-2020e)
10.2.1 Cumberland Pharmaceuticals Inc
10.2.2 Alveda Pharmaceuticals
10.2.3 Teligent
10.2.4 CSL Limited
10.2.5 Sandor Medicaids
10.2.6 Soho Industri Pharmasi
10.2.7 Germin MED
10.2.8 Grifols
10.2.9 Harbin Gloria Pharmaceuticals
10.2.10 Al Nabeel International Ltd
10.2.11 Laboratorios Valmorca
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT
  • FORMAT: PDF
  • PUBLISHED DATE: Jan, 2021
  • NO OF PAGES: 90